Naomi Balaban
8Patents
4h-index
3Co-inventors
42Inventor score
Filing activity: Apr 2, 1998 → May 26, 2006
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7067135B2 | Methods and compositions for the treatment and prevention of Staphylococcus aureus infections | Human Necessities | 11 | Expired |
| US6291431A | Methods and compositions for the treatment and prevention of Staphylococcal infections | Human Necessities | 6 | Expired |
| US7323179B2 | Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections | Human Necessities | 5 | Expired |
| US6747129B1 | Target of RNAIII activating protein(TRAP) | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6689878B2 | Target of RNAIII activating protein (TRAP) | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7534857B2 | Methods and compositions for the treatment and prevention of staphylococcal infections | Human Necessities | 2 | Expired |
| US7824691B2 | Use of RIP in treating staphylococcus aureus infections | Emerging Cross-Sectional Technologies | 1 | Active |
| US8067015B2 | Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.